Hepatitis Monthly

Published by: Kowsar

Drug-Resistance Associated Mutations in Polymerase (P) Gene of Hepatitis B Virus Isolated From Malaysian HBV Carriers

Jeyanthi Suppiah 1 , * , Rozainanee Mohd Zain 2 , Salbiah Haji Nawi 2 , Norazlah Bahari 3 and Zainah Saat 1
Authors Information
1 Virology Unit, Institute for Medical Research, Kuala Lumpur, Malaysia
2 Microbiology Unit, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia
3 Pathology Unit, Selayang Hospital, Selangor, Malaysia
Article information
  • Hepatitis Monthly: January 01, 2014, 14 (1); e13173
  • Published Online: January 5, 2014
  • Article Type: Research Article
  • Received: July 1, 2013
  • Revised: October 9, 2013
  • Accepted: November 1, 2013
  • DOI: 10.5812/hepatmon.13173

To Cite: Suppiah J, Mohd Zain R, Haji Nawi S, Bahari N, Saat Z. Drug-Resistance Associated Mutations in Polymerase (P) Gene of Hepatitis B Virus Isolated From Malaysian HBV Carriers, Hepat Mon. 2014 ; 14(1):e13173. doi: 10.5812/hepatmon.13173.

Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. MMWR. 2005; 54(16): 1-32
  • 2. Bowyer SM, Sim JG. Relationships within and between genotypes of hepatitis B virus at points across the genome: footprints of recombination in certain isolates. J Gen Virol. 2000; 81: 379-92[PubMed]
  • 3. Allen MI, Deslauriers M, Andrews CW, Tipples GA, Walters KA, Tyrrell DL, et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology. 1998; 27(6): 1670-7[DOI][PubMed]
  • 4. Har Ton So, Meng Tan Tsui, Siang Khoo Boo, Zawawi Mazlam, Thanaletchimy Nagalingam. Hepatitis B Virus Genotypes and Pre-core/Core Promoter Mutations in Malaysian Carriers. Malays J Biochem Mol Biol. 2005; 12: 14-20
  • 5. Ong HT, Duraisamy G, Kee Peng N, Wen Siang T, Seow HF. Genotyping of hepatitis B virus in Malaysia based on the nucleotide sequence of preS and S genes. Microbes Infect. 2005; 7(3): 494-500[DOI][PubMed]
  • 6. Sugauchi F, Mizokami M, Orito E, Ohno T, Kato H, Suzuki S, et al. A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J Gen Virol. 2001; 82: 883-92[PubMed]
  • 7. Brunjes PC. A comparative study of prenatal development in the olfactory bulb, neocortex and hippocampal region of the precocial mouse Acomys cahirinus and rat. Brain Res Dev Brain Res. 1989; 49(1): 7-25[PubMed]
  • 8. Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol. 2002; 83: 2059-73[PubMed]
  • 9. Tran TT, Trinh TN, Abe K. New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol. 2008; 82(11): 5657-63[DOI][PubMed]
  • 10. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol. 2009; 83(20): 10538-47[DOI][PubMed]
  • 11. Lim CK, Tan JT, Khoo JB, Ravichandran A, Low HM, Chan YC, et al. Correlations of HBV genotypes, mutations affecting HBeAg expression and HBeAg/ anti-HBe status in HBV carriers. Int J Med Sci. 2006; 3(1): 14-20[PubMed]
  • 12. Lindh M, Andersson AS, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method. J Infect Dis. 1997; 175(6): 1285-93[PubMed]
  • 13. Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology. 1995; 38(1-2): 24-34[PubMed]
  • 14. Schaefer S. Hepatitis B virus: significance of genotypes. J Viral Hepat. 2005; 12(2): 111-24[DOI][PubMed]
  • 15. Meldal BH, Bon AH, Prati D, Ayob Y, Allain JP. Diversity of hepatitis B virus infecting Malaysian candidate blood donors is driven by viral and host factors. J Viral Hepat. 2011; 18(2): 91-101[DOI][PubMed]
  • 16. Betka J, Valvoda M, Hruby J, Skrivan J. [The surgical approach and results of implantation of the Czech cochlear neuroprosthesis]. Cas Lek Cesk. 1989; 128(11): 339-41[PubMed]
  • 17. Schildgen O, Sirma H, Funk A, Olotu C, Wend UC, Hartmann H, et al. Variant of hepatitis B virus with primary resistance to adefovir. N Engl J Med. 2006; 354(17): 1807-12[DOI][PubMed]
  • 18. Tenney DJ, Rose RE, Baldick CJ, Pokornowski KA, Eggers BJ, Fang J, et al. Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5 years of therapy. Hepatology. 2009; 49(5): 1503-14[DOI][PubMed]
  • 19. Lai CL, Gane E, Liaw YF, Hsu CW, Thongsawat S, Wang Y, et al. Telbivudine versus lamivudine in patients with chronic hepatitis B. N Engl J Med. 2007; 357(25): 2576-88[DOI][PubMed]
  • 20. Fujisaki S, Yokomaku Y, Shiino T, Koibuchi T, Hattori J, Ibe S, et al. Outbreak of infections by hepatitis B virus genotype A and transmission of genetic drug resistance in patients coinfected with HIV-1 in Japan. J Clin Microbiol. 2011; 49(3): 1017-24[DOI][PubMed]
  • 21. Strasfeld L, Chou S. Antiviral drug resistance: mechanisms and clinical implications. Infect Dis Clin North Am. 2010; 24(2): 413-37[DOI][PubMed]
  • 22. Tacke F, Shirvani-Dastgerdi E. Impact of Drug-Resistance Polymerase Mutations on the Replication of HBeAg-Positive and HBeAg-Negative Hepatitis B Virus Strains in Vitro. Hepat Mon. 2012; 12(6): 357-60[DOI][PubMed]
  • 23. Fung S, Kwan P, Fabri MJ, Horban A, Petr Husa P, Hann HH, et al. Efficacy and safety of Tenofovir DF (TDF) in chronic hepatitis B virus infected patients with documented lamivudine resistance (LAM-R).: 2012;
  • 24. Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013; 381(9865): 468-75[DOI][PubMed]
  • 25. Lee YS, Suh DJ, Lim YS, Jung SW, Kim KM, Lee HC, et al. Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy. Hepatology. 2006; 43(6): 1385-91[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments